Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yajun Guo

Showing results (121-130 of 212) with videos related to

Pageof 22
Sort By:
Pharmaceuticals (Basel, Switzerland)|May 27, 2026
A Three-Arm, Tiered Comparability Strategy Bridging Post-Approval Process Changes for an Omalizumab Biosimilar (CMAB007)Chenguang Wang, Chaoxin Zhou, Sheng Hou, et al.
Blood|October 16, 2009
Characterization of a rituximab variant with potent antitumor activity against rituximab-resistant B-cell lymphomaBohua Li, Lei Zhao, Huaizu Guo, et al.
Stem Cells (Dayton, Ohio)|June 3, 2015
Osteopontin Promotes Hepatic Progenitor Cell Expansion and Tumorigenicity via Activation of β-Catenin in MiceYingying Liu, Lei Cao, Rui Chen, et al.
European Journal of Pharmacology|February 9, 2011
A humanized anti-osteopontin antibody protects from Concanavalin A induced-liver injury in miceKexing Fan, Bo Zhang, Haiou Yang, et al.
Biochemical and Biophysical Research Communications|April 17, 2010
Development and characterization of a novel anti-IgE monoclonal antibodyWeizhu Qian, Xunmin Zhang, Bohua Li, et al.
Protein Expression and Purification|October 24, 2007
Expression, purification, and characterization of an immunotoxin containing a humanized anti-CD25 single-chain fragment variable antibody fused to a modified truncated Pseudomonas exotoxin AHuajing Wang, Jianxin Dai, Bohua Li, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 27, 2013
Delta-like ligand 4 identifies a previously uncharacterized population of inflammatory dendritic cells that plays important roles in eliciting allogeneic T cell responses in miceKazuhiro Mochizuki, Fang Xie, Shan He, et al.
Biomed Research International|December 26, 2013
Nano polymeric carrier fabrication technologies for advanced antitumor therapyWei Li, Mengxin Zhao, Changhong Ke, et al.
Drug Design, Development and Therapy|March 19, 2019
Physicochemical characterization and phase I study of CMAB008, an infliximab biosimilar produced by a different expression systemQing An, Yingxin Zheng, Yirong Zhao, et al.
Cancer Research|April 3, 2008
Development of novel tetravalent anti-CD20 antibodies with potent antitumor activityBohua Li, Shu Shi, Weizhu Qian, et al.
Pageof 22

Showing results (121-130 of 212) with videos related to

Sort By:
Pageof 22
Pharmaceuticals (Basel, Switzerland)|May 27, 2026
A Three-Arm, Tiered Comparability Strategy Bridging Post-Approval Process Changes for an Omalizumab Biosimilar (CMAB007)Chenguang Wang, Chaoxin Zhou, Sheng Hou, et al.
Blood|October 16, 2009
Characterization of a rituximab variant with potent antitumor activity against rituximab-resistant B-cell lymphomaBohua Li, Lei Zhao, Huaizu Guo, et al.
Stem Cells (Dayton, Ohio)|June 3, 2015
Osteopontin Promotes Hepatic Progenitor Cell Expansion and Tumorigenicity via Activation of β-Catenin in MiceYingying Liu, Lei Cao, Rui Chen, et al.
European Journal of Pharmacology|February 9, 2011
A humanized anti-osteopontin antibody protects from Concanavalin A induced-liver injury in miceKexing Fan, Bo Zhang, Haiou Yang, et al.
Biochemical and Biophysical Research Communications|April 17, 2010
Development and characterization of a novel anti-IgE monoclonal antibodyWeizhu Qian, Xunmin Zhang, Bohua Li, et al.
Protein Expression and Purification|October 24, 2007
Expression, purification, and characterization of an immunotoxin containing a humanized anti-CD25 single-chain fragment variable antibody fused to a modified truncated Pseudomonas exotoxin AHuajing Wang, Jianxin Dai, Bohua Li, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 27, 2013
Delta-like ligand 4 identifies a previously uncharacterized population of inflammatory dendritic cells that plays important roles in eliciting allogeneic T cell responses in miceKazuhiro Mochizuki, Fang Xie, Shan He, et al.
Biomed Research International|December 26, 2013
Nano polymeric carrier fabrication technologies for advanced antitumor therapyWei Li, Mengxin Zhao, Changhong Ke, et al.
Drug Design, Development and Therapy|March 19, 2019
Physicochemical characterization and phase I study of CMAB008, an infliximab biosimilar produced by a different expression systemQing An, Yingxin Zheng, Yirong Zhao, et al.
Cancer Research|April 3, 2008
Development of novel tetravalent anti-CD20 antibodies with potent antitumor activityBohua Li, Shu Shi, Weizhu Qian, et al.
Pageof 22